Nothing Special   »   [go: up one dir, main page]

Borang DRS Annex1

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 1

DRS_Annex1

National Surveillance of Drug Response Against


Malaria Parasite (P.falciparum, P.vivax, P.malariae, P.ovale and P.knowlesi)

Note: This form is to be completed for all cases of P.falciparum, P.vivax, P.malariae, P.ovale and P.knowlesi seen and treated with
the first line drugs at the all hospitals/clinics.

INFORMANT
1 Hospital State
Name of Reporting Officer Designation of Reporting Officer
Medical Officer
Coordinator
2
PATIENT'S DEMOGRAPHIC DATA
Patient's Initial Patient's ID (Reg. No/NRIC)
Gender ( / ) Body
Age (Years) Ethnic
Male Female weight
3
DRUG/MEDICATION HISTORY
Actual number of tablet given to and taken by the patient
Day of treatment ASMQ Others (Specify) :
AL
Adult dose Paeds dose
D0
D1
D2
4
PARASITE RESPONSE
P.falciparum P.vivax P.malariae
Type of parasite ( / )
P.ovale
P.knowlesi
Follow-up slide post treatment Parasite density (per UL blood)
Day Date Due* Actual Date** Asexual Sexual (gametocyte)
D0
D3
D7
D14
D21
D28
D42
5
CASE INVESTIGATION
Was this patient treated before for No
malaria ( / ) Yes
What type of medication ? (if known)
When was medication taken ?
(eg : 1 week/month prior to current
treatment)
Probable Source of Infection in This Local
Case ( / )
Imported From where?

6 VERIFICATION AND VALIDATION (Epid. Officer/MOH)


Name Signature

AL= Artementher-Lumefantrine (Riamet) ASMQ=Artesunate-Mefloquine


D0= Day of starting the treatment
* Enter the day due for the subsequent post-treatment follow-up (D3,D7,D14,D21,D28,D42)
** Enter the actual date of slide collection during follow-up

You might also like